Overview of Specifications to the ACMG/AMP Variant Interpretation Guidelines
- PMID: 31479589
- PMCID: PMC6885382
- DOI: 10.1002/cphg.93
Overview of Specifications to the ACMG/AMP Variant Interpretation Guidelines
Abstract
The 2015 ACMG/AMP guidelines established a classification system for sequence variants; however, the broad scope of these guidelines necessitates specification of evidence types for specific genes or diseases of interest. Since publication of the guidelines, both general use and disease-focused specifications have emerged to aid in accurate application of ACMG/AMP evidence types. This article summarizes the approaches to, and rationale for, specifying three evidence categories (population frequency data, variant type and location, and case-level data), including available resources and a quantitative framework that can inform the specification process. © 2019 by John Wiley & Sons, Inc.
Keywords: ACMG/AMP guidelines; clinical genetics; variant interpretation.
© 2019 John Wiley & Sons, Inc.
References
-
- Amendola LM, Jarvik GP, Leo MC, McLaughlin HM, Akkari Y, Amaral MD, … Rehm HL (2016). Performance of ACMG-AMP Variant-Interpretation Guidelines among Nine Laboratories in the Clinical Sequencing Exploratory Research Consortium. American Journal of Human Genetics, 98(6), 1067–1076. 10.1016/j.ajhg.2016.03.024 - DOI - PMC - PubMed
-
- Gelb BD, Cavé H, Dillon MW, Gripp KW, Lee JA, Mason-Suares H, … ClinGen RASopathy Working Group. (2018). ClinGen’s RASopathy Expert Panel consensus methods for variant interpretation. Genetics in Medicine: Official Journal of the American College of Medical Genetics, 20(11), 1334–1345. 10.1038/gim.2018.3 - DOI - PMC - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical